Biological E gets drug regulator's approval to conduct phase 2/3 trials on children

Meanwhile, Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D has already received emergency use authorisation (EUA) to inoculate children in the age group of 12-18. It is expected to be administered from the first week of October.

migrator

Updated:2nd Sep, 2021 at 10:24 AM

New Delhi

The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain conditions, sources told ANI. The trial will be conducted in ten locations.

The permission has been given to Biological E after the recommendation from the Subject Expert Committee. Meanwhile, Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D has already received emergency use authorisation (EUA) to inoculate children in the age group of 12-18. It is expected to be administered from the first week of October.

The trials of Bharat Biotech's Covaxin COVID-19 vaccine for phases 2 & 3 for children are underway, and its result is expected in September. It is to be noted that the government has made an advance payment of Rs 1,500 crore to Biological E for 30 crore vaccines.

Biological E gets drug regulator's approval to conduct phase 2/3 trials on children

Meanwhile, Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D has already received emergency use authorisation (EUA) to inoculate children in the age group of 12-18. It is expected to be administered from the first week of October.

Also Read

Veeramani case under CM Vijay’s direct supervision, says Minister Rajmohan

ECI must not only be independent but also be seen to act independently: Justice Dipankar Datta

'One-man autocracy' under CEC, Gyanesh Kumar must be removed: Oppn after report on differences in poll panel

Submerged Chola port city yields fresh secrets, throws up torpedo jar during exploration

TN nurses body announces agitation over contractual appointments